πŸ‡ΊπŸ‡Έ FDA
Patent

US 10442864

Anti-Tie2 antibodies and uses thereof

granted A61KA61K2039/505A61K39/395

Quick answer

US patent 10442864 (Anti-Tie2 antibodies and uses thereof) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K2039/505, A61K39/395, A61K39/39533, A61K39/3955